US HEVA Dupixent Team Lead

Responsibilities

• Lead US HEVA strategy and execution for Dupixent across indications, ensuring generation, translation, and dissemination of high‑quality decision‑relevant evidence to impact US access.
• Drive measurable US HEVA business impact aligned to US commercial objectives and market access goals.
• Develop and execute US HEVA strategies aligned with Global HEVA strategy; partner with commercial teams to translate HEVA insights into business strategy.
• Provide exceptional leadership, mentor team members, drive change/process improvements, and represent HEVA with US Dupixent Franchise Leadership Team.
• Build cross‑functional partnerships to support pricing/access decisions with robust evidence (including real‑world evidence); align with Global HEVA to coordinate evidence generation, modelling, and synthesis.
• Present complex health economics concepts to senior leadership; influence key decisions via data‑driven HEVA recommendations; ensure clinical development plans enable differentiation.
• Oversee design, execution, publication, and dissemination of health economics and outcomes research; develop real‑world evidence strategies.
• Ensure scientific rigor and regulatory compliance; manage US launch/evidence generation plans and provide HEVA input to Integrated Evidence Generation Plans (IEGPs).
• Lead compliant HEOR dissemination and proactive/promotional use with US stakeholders (e.g., HCEI/PIE, consistent with FDA label).
• Partner with Access Strategy and US Market Access to execute payer partnership studies and analytics.
• Engage external stakeholders (payers, HTA bodies, academics); represent Sanofi at major conferences; collaborate with KOLs/partners; engage evidence bodies (e.g., ICER, PDAB, IRA).

• Minimum 10 years in health economics, outcomes research, or related field.
• Advanced degree (PhD, PharmD, Masters or equivalent) in health economics, epidemiology, public health, economics, or related field (required).
• Expertise in health economic modeling, real‑world evidence generation, and outcomes research.
• Deep knowledge of US healthcare, payer dynamics, and policy; track record translating evidence into strategic impact.
• Proven experience supporting market access/reimbursement and influencing decision‑making using HEVA insights.
• Strong US evidence dissemination experience (HCEI/PIE, reactive/proactive, CFL, AMCP dossiers).
• Exceptional leadership, change management, and cross‑functional collaboration skills.
• Extensive immunology experience (disease pathophysiology, treatment paradigms, market dynamics).
• Strong written/verbal English communication; ability to synthesize complex data into actionable recommendations.
• 20% domestic/international travel.

Health and wellbeing benefits including high‑quality healthcare, prevention and wellness programs, and at least 14 weeks’ gender‑neutral parental leave.